Adam R. Levy - 02 Jan 2025 Form 4 Insider Report for NEXGEL, INC. (NXGL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jan 2025, 16:37:06 UTC
Prior SEC filing
22 Nov 2024
Next SEC filing
05 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Adam R. Levy

Key filing fact

Adam R. Levy filed Form 4 for NEXGEL, INC. (NXGL) on 06 Jan 2025.

Key facts

  • This page summarizes Adam R. Levy's Form 4 filing for NEXGEL, INC. (NXGL).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Jan 2025, 16:37.

Change

  • Previous filing in this sequence was filed on 22 Nov 2024.
  • Current net transaction value: -$15,828.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NXGL transaction

Common Stock (restricted stock units)

Award

Transaction value
$0
Shares
+26,116
Change %
+7.3%
Price
$0.000000
Shares after
386,284
Date
02 Jan 2025
Ownership
Direct
Footnotes
F1
NXGL transaction

Common Stock

Sale

Transaction value
$15,828
Shares
-4,000
Change %
-1%
Price
$3.96
Shares after
382,284
Date
02 Jan 2025
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NXGL transaction Derivative

Stock Options (right to buy)

Award

Transaction value
$0
Shares
+150,000
Change %
Price
$0.000000
Shares after
150,000
Date
02 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Exercise price
$3.83
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The restricted stock units were granted to the Reporting Person in connection with his 2025 executive employment agreement with the Issuer. The restricted stock units vest in twelve equal monthly installments (subject to any rounding adjustments) during the term of the Levy Employment Agreement with the first installment vesting on January 2, 2025 provided the Reporting Person is employed on the applicable vesting date by the Issuer.

Footnote F2

The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan instituted for tax planning purposes. The shares were originally acquired by the Reporting Person from the Issuer on October 15, 2019 and were not purchased in the recent registered direct offerings of the Issuer.

Footnote F3

Represents the weighted average of open market sale transactions ranging from $3.61 to $4.42 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

Footnote F4

The stock options were granted to the Reporting Person in connection with his 2025 executive employment agreement with the Issuer. The stock options vest as follows: 37,500 shares of Common Stock on December 31, 2025, 2026, 2027 and 2028, respectively, provided the Reporting Person is employed on the applicable vesting date by the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .